Fidelity Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $353M | Buy |
12,567,358
+292,218
| +2% | +$7.78M | 0.02% | 638 |
|
|
2025
Q4 | $306M | Sell |
12,275,140
-2,125,995
| -15% | -$53.6M | 0.02% | 688 |
|
|
2025
Q3 | $367M | Sell |
14,401,135
-3,348,538
| -19% | -$82.6M | 0.02% | 617 |
|
|
2025
Q2 | $430M | Buy |
17,749,673
+3,732,975
| +27% | +$87.1M | 0.02% | 543 |
|
|
2025
Q1 | $355M | Buy |
14,016,698
+3,260,678
| +30% | +$85.3M | 0.02% | 584 |
|
|
2024
Q4 | $285M | Sell |
10,756,020
-3,722,469
| -26% | -$101M | 0.02% | 677 |
|
|
2024
Q3 | $419M | Buy |
14,478,489
+435,311
| +3% | +$12.7M | 0.03% | 543 |
|
|
2024
Q2 | $393M | Buy |
14,043,178
+1,435,790
| +11% | +$39.5M | 0.03% | 535 |
|
|
2024
Q1 | $350M | Buy |
12,607,388
+2,606,078
| +26% | +$72.3M | 0.02% | 574 |
|
|
2023
Q4 | $288M | Sell |
10,001,310
-1,531,708
| -13% | -$46.3M | 0.02% | 607 |
|
|
2023
Q3 | $383M | Sell |
11,533,018
-1,549,720
| -12% | -$54.8M | 0.03% | 472 |
|
|
2023
Q2 | $480M | Buy |
13,082,738
+712,456
| +6% | +$27.7M | 0.04% | 433 |
|
|
2023
Q1 | $505M | Sell |
12,370,282
-350,785
| -3% | -$15.2M | 0.05% | 400 |
|
|
2022
Q4 | $652M | Sell |
12,721,067
-8,716,461
| -41% | -$418M | 0.06% | 301 |
|
|
2022
Q3 | $938M | Buy |
21,437,528
+712,884
| +3% | +$34.6M | 0.1% | 185 |
|
|
2022
Q2 | $1.09B | Buy |
20,724,644
+2,935,073
| +16% | +$150M | 0.11% | 166 |
|
|
2022
Q1 | $921M | Buy |
17,789,571
+7,499,739
| +73% | +$389M | 0.07% | 250 |
|
|
2021
Q4 | $608M | Buy |
10,289,832
+2,062,455
| +25% | +$102M | 0.04% | 386 |
|
|
2021
Q3 | $354M | Buy |
8,227,377
+3,951,437
| +92% | +$175M | 0.03% | 556 |
|
|
2021
Q2 | $167M | Sell |
4,275,940
-2,899,010
| -40% | -$113M | 0.01% | 890 |
|
|
2021
Q1 | $260M | Sell |
7,174,950
-538,460
| -7% | -$19.1M | 0.02% | 670 |
|
|
2020
Q4 | $284M | Buy |
7,713,410
+233,245
| +3% | +$8.56M | 0.03% | 605 |
|
|
2020
Q3 | $260M | Buy |
7,480,165
+705,933
| +10% | +$24.8M | 0.03% | 542 |
|
|
2020
Q2 | $210M | Sell |
6,774,232
-242,858
| -3% | -$8.25M | 0.02% | 593 |
|
|
2020
Q1 | $217M | Sell |
7,017,090
-1,178,891
| -14% | -$40.2M | 0.03% | 481 |
|
|
2019
Q4 | $305M | Buy |
8,195,981
+233,195
| +3% | +$8.31M | 0.03% | 481 |
|
|
2019
Q3 | $271M | Sell |
7,962,786
-1,171,714
| -13% | -$42.6M | 0.03% | 510 |
|
|
2019
Q2 | $375M | Sell |
9,134,500
-1,959,183
| -18% | -$77.8M | 0.04% | 411 |
|
|
2019
Q1 | $447M | Sell |
11,093,683
-683,995
| -6% | -$27.4M | 0.05% | 342 |
|
|
2018
Q4 | $488M | Sell |
11,777,678
-3,930,138
| -25% | -$163M | 0.07% | 288 |
|
|
2018
Q3 | $657M | Sell |
15,707,816
-2,719,710
| -15% | -$105M | 0.07% | 252 |
|
|
2018
Q2 | $634M | Sell |
18,427,526
-3,598,732
| -16% | -$123M | 0.07% | 256 |
|
|
2018
Q1 | $742M | Sell |
22,026,258
-2,672,441
| -11% | -$91.9M | 0.09% | 241 |
|
|
2017
Q4 | $849M | Sell |
24,698,699
-1,543,681
| -6% | -$52.6M | 0.1% | 217 |
|
|
2017
Q3 | $889M | Buy |
26,242,380
+6,548,024
| +33% | +$210M | 0.11% | 196 |
|
|
2017
Q2 | $628M | Buy |
19,694,356
+35,482
| +0.2% | +$1.12M | 0.08% | 262 |
|
|
2017
Q1 | $638M | Sell |
19,658,874
-3,497,862
| -15% | -$110M | 0.08% | 259 |
|
|
2016
Q4 | $714M | Buy |
23,156,736
+4,172,073
| +22% | +$127M | 0.1% | 225 |
|
|
2016
Q3 | $610M | Sell |
18,984,663
-8,467,374
| -31% | -$283M | 0.08% | 258 |
|
|
2016
Q2 | $917M | Sell |
27,452,037
-14,360,343
| -34% | -$458M | 0.13% | 169 |
|
|
2016
Q1 | $1.18B | Buy |
41,812,380
+4,760,018
| +13% | +$136M | 0.16% | 127 |
|
|
2015
Q4 | $1.13B | Buy |
37,052,362
+1,396,529
| +4% | +$43.9M | 0.15% | 138 |
|
|
2015
Q3 | $1.06B | Buy |
35,655,833
+4,440,640
| +14% | +$142M | 0.15% | 139 |
|
|
2015
Q2 | $993M | Sell |
31,215,193
-16,928,205
| -35% | -$552M | 0.13% | 169 |
|
|
2015
Q1 | $1.59B | Buy |
48,143,398
+3,067,179
| +7% | +$97.5M | 0.2% | 104 |
|
|
2014
Q4 | $1.33B | Buy |
45,076,219
+2,786,814
| +7% | +$79.9M | 0.17% | 122 |
|
|
2014
Q3 | $1.19B | Sell |
42,289,405
-2,310,804
| -5% | -$64.9M | 0.16% | 132 |
|
|
2014
Q2 | $1.26B | Sell |
44,600,209
-5,376,263
| -11% | -$153M | 0.17% | 124 |
|
|
2014
Q1 | $1.52B | Sell |
49,976,472
-17,036,497
| -25% | -$508M | 0.21% | 93 |
|
|
2013
Q4 | $1.95B | Sell |
67,012,969
-15,908,407
| -19% | -$463M | 0.28% | 67 |
|
|
2013
Q3 | $2.26B | Sell |
82,921,376
-18,345,988
| -18% | -$499M | 0.35% | 54 |
|
|
2013
Q2 | $2.69B | Buy |
+101,267,364
| New | +$2.8B | 0.44% | 39 |
|
Other funds holding PFE
VCM
VPM
Fidelity Investments's PFE Position: Q1 2026 in Review
Fidelity Investments increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $7.78M and bringing the position to 12,567,358 shares worth $353M. The position accounts for 0.02% of the portfolio, ranked #638.
Fidelity Investments first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.69B in Q2 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Fidelity Investments held 12,567,358 shares of Pfizer worth $353M as of Q1 2026.
- Fidelity Investments bought 292,218 Pfizer shares in Q1 2026, an estimated $7.78M.
- Pfizer made up 0.02% of Fidelity Investments's portfolio in Q1 2026, its #638 holding.
- Fidelity Investments first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Pfizer position peaked at $2.69B in Q2 2013.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.